Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:carboplatin (1:1 mol/mol) |
PharmacoGx | BRD-A02303741:carboplatin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SHANK1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
mRNA | PCDH17 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
mRNA | HSPA9 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
mRNA | RASGEF1C | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
mRNA | POLR2G | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
mRNA | LMNTD2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
mRNA | SDHB | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
mRNA | C2orf50 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
mRNA | MATR3 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
mRNA | AP4E1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |